Selected research
Industry Research
Modafinil Oral Drugs Industry Research Report 2026
Market perspective
The global Modafinil Oral Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Modafinil Oral Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Modafinil Oral Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Modafinil Oral Drugs include Xiangbei Welman Pharmaceutical, Zydus, Watson Labs, Sun Pharmaceutical, Orbion Pharmaceuticals, Cephalon, Aurobindo Pharma, Apotex and Alembic Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Modafinil Oral Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Modafinil Oral Drugs Market by Company
Xiangbei Welman Pharmaceutical
Zydus
Watson Labs
Sun Pharmaceutical
Orbion Pharmaceuticals
Cephalon
Aurobindo Pharma
Apotex
Alembic Pharma
Modafinil Oral Drugs Segment by Type
Tablets
Capsules
Modafinil Oral Drugs Segment by Application
Obstructive Sleep Apnea
Shift Work Sleep Disorder
Narcolepsy
Other
Modafinil Oral Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Modafinil Oral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Modafinil Oral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Modafinil Oral Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Modafinil Oral Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Modafinil Oral Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Modafinil Oral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
Applications
- Obstructive Sleep Apnea
- Shift Work Sleep Disorder
- Narcolepsy
- Other
Companies covered
- Xiangbei Welman Pharmaceutical
- Zydus
- Watson Labs
- Sun Pharmaceutical
- Orbion Pharmaceuticals
- Cephalon
- Aurobindo Pharma
- Apotex
- Alembic Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Modafinil Oral Drugs Market Size (2021-2032)
- 2.2.2 Global Modafinil Oral Drugs Sales (2021-2032)
- 2.2.3 Global Modafinil Oral Drugs Market Average Price (2021-2032)
- 2.3 Modafinil Oral Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Capsules
- 2.4 Modafinil Oral Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Obstructive Sleep Apnea
- 2.4.3 Shift Work Sleep Disorder
- 2.4.4 Narcolepsy
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Modafinil Oral Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Modafinil Oral Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Modafinil Oral Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Modafinil Oral Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Modafinil Oral Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Modafinil Oral Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Modafinil Oral Drugs, Product Type & Application
- 3.8 Global Manufacturers of Modafinil Oral Drugs, Established Date
- 3.9 Global Modafinil Oral Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Xiangbei Welman Pharmaceutical
- 4.1.1 Xiangbei Welman Pharmaceutical Company Information
- 4.1.2 Xiangbei Welman Pharmaceutical Business Overview
- 4.1.3 Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Product Portfolio
- 4.1.5 Xiangbei Welman Pharmaceutical Recent Developments
- 4.2 Zydus
- 4.2.1 Zydus Company Information
- 4.2.2 Zydus Business Overview
- 4.2.3 Zydus Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zydus Modafinil Oral Drugs Product Portfolio
- 4.2.5 Zydus Recent Developments
- 4.3 Watson Labs
- 4.3.1 Watson Labs Company Information
- 4.3.2 Watson Labs Business Overview
- 4.3.3 Watson Labs Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Watson Labs Modafinil Oral Drugs Product Portfolio
- 4.3.5 Watson Labs Recent Developments
- 4.4 Sun Pharmaceutical
- 4.4.1 Sun Pharmaceutical Company Information
- 4.4.2 Sun Pharmaceutical Business Overview
- 4.4.3 Sun Pharmaceutical Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sun Pharmaceutical Modafinil Oral Drugs Product Portfolio
- 4.4.5 Sun Pharmaceutical Recent Developments
- 4.5 Orbion Pharmaceuticals
- 4.5.1 Orbion Pharmaceuticals Company Information
- 4.5.2 Orbion Pharmaceuticals Business Overview
- 4.5.3 Orbion Pharmaceuticals Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Orbion Pharmaceuticals Modafinil Oral Drugs Product Portfolio
- 4.5.5 Orbion Pharmaceuticals Recent Developments
- 4.6 Cephalon
- 4.6.1 Cephalon Company Information
- 4.6.2 Cephalon Business Overview
- 4.6.3 Cephalon Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Cephalon Modafinil Oral Drugs Product Portfolio
- 4.6.5 Cephalon Recent Developments
- 4.7 Aurobindo Pharma
- 4.7.1 Aurobindo Pharma Company Information
- 4.7.2 Aurobindo Pharma Business Overview
- 4.7.3 Aurobindo Pharma Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Aurobindo Pharma Modafinil Oral Drugs Product Portfolio
- 4.7.5 Aurobindo Pharma Recent Developments
- 4.8 Apotex
- 4.8.1 Apotex Company Information
- 4.8.2 Apotex Business Overview
- 4.8.3 Apotex Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Apotex Modafinil Oral Drugs Product Portfolio
- 4.8.5 Apotex Recent Developments
- 4.9 Alembic Pharma
- 4.9.1 Alembic Pharma Company Information
- 4.9.2 Alembic Pharma Business Overview
- 4.9.3 Alembic Pharma Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Alembic Pharma Modafinil Oral Drugs Product Portfolio
- 4.9.5 Alembic Pharma Recent Developments
5 Global Modafinil Oral Drugs Market Scenario by Region
- 5.1 Global Modafinil Oral Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Modafinil Oral Drugs Sales by Region: 2021-2032
- 5.2.1 Global Modafinil Oral Drugs Sales by Region: 2021-2026
- 5.2.2 Global Modafinil Oral Drugs Sales by Region: 2027-2032
- 5.3 Global Modafinil Oral Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Modafinil Oral Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Modafinil Oral Drugs Revenue by Region: 2027-2032
- 5.4 North America Modafinil Oral Drugs Market Facts & Figures by Country
- 5.4.1 North America Modafinil Oral Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Modafinil Oral Drugs Sales by Country (2021-2032)
- 5.4.3 North America Modafinil Oral Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Modafinil Oral Drugs Market Facts & Figures by Country
- 5.5.1 Europe Modafinil Oral Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Modafinil Oral Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Modafinil Oral Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Modafinil Oral Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Modafinil Oral Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Modafinil Oral Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Modafinil Oral Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Modafinil Oral Drugs Market Facts & Figures by Country
- 5.7.1 South America Modafinil Oral Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Modafinil Oral Drugs Sales by Country (2021-2032)
- 5.7.3 South America Modafinil Oral Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Modafinil Oral Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Modafinil Oral Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Modafinil Oral Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Modafinil Oral Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Modafinil Oral Drugs Sales by Type (2021-2032)
- 6.1.1 Global Modafinil Oral Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Modafinil Oral Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Modafinil Oral Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Modafinil Oral Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Modafinil Oral Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Modafinil Oral Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Modafinil Oral Drugs Sales by Application (2021-2032)
- 7.1.1 Global Modafinil Oral Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Modafinil Oral Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Modafinil Oral Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Modafinil Oral Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Modafinil Oral Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Modafinil Oral Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Modafinil Oral Drugs Value Chain Analysis
- 8.1.1 Modafinil Oral Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Modafinil Oral Drugs Production Mode & Process
- 8.2 Modafinil Oral Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Modafinil Oral Drugs Distributors
- 8.2.3 Modafinil Oral Drugs Customers
9 Global Modafinil Oral Drugs Analyzing Market Dynamics
- 9.1 Modafinil Oral Drugs Industry Trends
- 9.2 Modafinil Oral Drugs Industry Drivers
- 9.3 Modafinil Oral Drugs Industry Opportunities and Challenges
- 9.4 Modafinil Oral Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst